$DSGN - Russell 2000 Wholesale

Wholesale Area: $2 -$8

Retail Area: $22 -$25

Golden Ratio: $45

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease.
Chart PatternsTechnical IndicatorsTrend Analysis

Również na:

Wyłączenie odpowiedzialności